Pathwork Diagnostics

Invested in innovation

Pathwork Diagnostics' business model is based on innovative, high-value molecular tests in oncology, with a focused strategy for commercialization and a promising product pipeline. We work closely with these investors, who share our commitment to innovations that contribute to better patient care.

Abingworth is an international group dedicated to investment in the life sciences and healthcare industries.

Advent Venture Partners has backed more than 200 companies, with a focus on early- and late-stage development in the life sciences and technology.

Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in the industry since 1996. Its diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for its companies and investors.

Novus Ventures seeks new ventures in information technology, supporting enterprise software, infrastructure and intellectual property firms.

Prospect Venture Partners invests in biomedical enterprises that offer entrepreneurial management teams, proprietary products and innovative technologies.

Venrock is the venture capital enterprise of the Rockefeller family, providing funding for breakthrough ideas in technology, healthcare, media and energy.

Versant Ventures provides early-stage investment in medical devices, biotechnology, pharmaceuticals and healthcare information technology.